Clinical Trial Update: Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in OSA [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating JZP-110 effect on driving performance in adults with obstructive sleep apnea and excessive sleepiness has completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Excessive Sleepiness
• Obstructive Sleep Apnea

Drugs mentioned

• JZP-110

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Obstructive Sleep Apnea, Excessive Sleepiness | Phase 2 | Status: COMPLETED | Results posted: 2020-06-16